InsiderTrades

Form 4 for CC Chemours Co

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001627223-22-000017 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-03 2022-03-01 CC Newman Mark Pres, CEO, Dir F - Tax $25.98 -1,253 156.6K -0.8% -$32.6K
D 2022-03-03 2022-03-01 CC Newman Mark Pres, CEO, Dir A - Grant $0.00 +19.6K 176.3K +13% $0
D 2022-03-03 2022-03-01 CC Newman Mark Pres, CEO, Dir A - Grant $0.00 +206.3K 206.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-01 F D 1,253 $25.98 156,623.06 D — — (F1) Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units.
2 Common Common Stock 2022-03-01 A A 19,630 $0.00 176,253.06 D — — (F3) Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2023. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units.
3 Derivative Stock Option (Right to Buy) 2022-03-01 A A 206,268 $0.00 206,268 D $25.98 · — to 2032-03-01 206,268 Common Stock (F4) These options are scheduled to vest in three equal annual installments beginning on March 1, 2023.